News Earnings Max Healthcare Institute Schedules Board Meeting on February 5, 2026 for Q3FY26 Financial ResultsMax Healthcare Institute Schedules Board Meeting on February 5, 2026 for Q3FY26 Financial Results
Max Healthcare Institute Limited has scheduled its Board of Directors meeting for February 5, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The company has notified both NSE and BSE in compliance with SEBI Regulation 29, while maintaining trading window closure for designated persons until 48 hours after results declaration. The disclosure will be made available on the company's official website, ensuring comprehensive stakeholder communication.
*this image is generated using AI for illustrative purposes only.
Max healthcare institute has officially notified stock exchanges about its upcoming board meeting scheduled for February 5, 2026, where directors will review and approve the company's quarterly financial performance. The meeting represents a key milestone in the company's financial reporting calendar as stakeholders await insights into the healthcare provider's operational and financial performance.
Board Meeting Details
The company has formally communicated to both the National Stock Exchange of India Limited and BSE Limited regarding the board meeting scheduled for Thursday, February 5, 2026. The primary agenda involves consideration and approval of unaudited standalone and consolidated financial results covering two distinct periods.
| Meeting Parameter: | Details |
|---|---|
| Date: | February 5, 2026 |
| Purpose: | Financial Results Approval |
| Results Period: | Quarter ended December 31, 2025 |
| Extended Period: | Nine months ended December 31, 2025 |
| Result Type: | Unaudited standalone and consolidated |
Regulatory Compliance and Trading Window
In accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Max Healthcare Institute has maintained transparency by providing advance notice of the board meeting. The company has implemented trading restrictions as part of its compliance framework.
The trading window closure affects specific categories of individuals and extends beyond the meeting date to ensure fair disclosure practices. This restriction continues from the earlier intimation dated December 29, 2025, demonstrating the company's adherence to regulatory timelines.
| Trading Restriction: | Details |
|---|---|
| Affected Persons: | All designated persons and immediate relatives |
| Closure Period: | Until 48 hours after results declaration |
| Initial Closure Date: | December 29, 2025 |
| Regulatory Basis: | SEBI compliance requirements |
Communication and Disclosure
The company has ensured comprehensive communication by notifying both major stock exchanges where its securities are listed. Max Healthcare Institute trades on NSE under the symbol MAXHEALTH and on BSE with scrip code 543220. The formal communication was signed by Dhiraj Aroraa, SVP - Company Secretary and Compliance Officer, on January 28, 2026.
Additionally, the company has committed to hosting this disclosure on its official website at www.maxhealthcare.in , ensuring broader accessibility for stakeholders and maintaining transparency in its communication approach. This multi-channel disclosure strategy aligns with best practices in corporate governance and regulatory compliance.
Historical Stock Returns for Max Healthcare Institute
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.63% | -5.14% | -11.33% | -24.24% | -6.76% | +487.30% |
19
